Status:
UNKNOWN
(ACTH) for the Treatment of Sarcoid Uveitis
Lead Sponsor:
John Huang, MD
Conditions:
Sarcoid Uveitis
Eligibility:
All Genders
Brief Summary
Sarcoidosis is a multisystem granulomatous disease that can affect nearly any organ in the body. While most commonly affecting the lungs, vision threatening eye involvement occurs in approximately 25%...
Detailed Description
The Investigator seeks to determine the efficacy of H.P. Acthar® Gel (40 units twice weekly injection) of on disease activity and severity in patients with sarcoid uveitis. The retrospective study wil...
Eligibility Criteria
Inclusion
- Presence of Sarcoid Uveitis as determined by
- clinical exam
- fluorescence angiography
- optical coherence tomography
Exclusion
- Presence of long acting intraocular depots
- Women of childbearing age not using contraceptives
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03473964
Start Date
April 1 2018
End Date
January 1 2020
Last Update
March 22 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New England Retina Associates
Hamden, Connecticut, United States, 06518